Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation
- 9 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in neurogenetics
- Vol. 22 (4), 323-332
- https://doi.org/10.1007/s10048-021-00649-2
Abstract
Mutations in CSNK2B lead to Poirier-Bienvenu neurodevelopmental syndrome (POBINDS), a rare neurodevelopmental disorder. Only 14 cases of POBINDS have been reported worldwide. The main manifestations are seizures, often tonic–clonic, with or without intellectual disability, growth retardation, and developmental language retardation. We conducted a comprehensive phenotypic mining and trio-whole exome sequencing on six children with POBINDS for gene diagnosis and analyzed the different variants using bioinformatics analysis software and related experiments. This paper reviews previous literature and discusses two common missense variants that lead to structural changes. Among the six patients, four, one, and one had tonic–clonic, myoclonic, and febrile seizures, respectively. Language development disorder, motor development disorder, and developmental delay/intellectual disability (DD/ID) are the main clinical features. All children had de novo mutations in CSNK2B, including three missense variants (c.410G > T/p.(Cys137Phe), c.494A > G/p.(His165Arg), and c.3G > A/p.(Met1Ile)), two splice variants (c.292-2A > T, c.558-3 T > G), and one frameshift variant (c.499delC/p.(Leu167Serfs*60)). Three missense variants were predicted to be harmful by various software programs, and two splicing variants were found to produce new exonic splicing enhancers by the minigene assay. Western blot analysis showed that the frameshift variant resulted in decreased protein expression. According to a literature review, c.3G > A/p.(Met1Ile), c.292-2A > T, c.558-3 T > G, and c.499delC/p.(Leu167Serfs*60) are novel variants of CSNK2B. The decrease or loss of protein function caused by CSNK2B mutations may be a pathogenic factor in this cohort. The severity of the POBINDS phenotype differs, and refractory epilepsy may be accompanied by a more serious DD/ID, language disorder, and motor retardation. At present, there is no specific treatment, and antiepileptic therapy usually requires the combination of two or more anti-epileptic drugs.This publication has 25 references indexed in Scilit:
- Germline de novo variants in CSNK2B in Chinese patients with epilepsyScientific Reports, 2019
- Extending the phenotype associated with the CSNK2A1‐ related Okur–Chung syndrome—A clinical study of 11 individualsAmerican Journal of Medical Genetics Part A, 2018
- Okur‐Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansionClinical Genetics, 2017
- CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsyHuman Mutation, 2017
- Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activityJournal of Cellular Physiology, 2010
- Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemiaBlood, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Predicting the Effects of Amino Acid Substitutions on Protein FunctionAnnual Review of Genomics and Human Genetics, 2006
- Casein Kinase 2 Is Activated and Essential for Wnt/β-Catenin SignalingOnline Journal of Public Health Informatics, 2006
- Recombinant human casein kinase IIJBIC Journal of Biological Inorganic Chemistry, 1994